Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 May;116(10):741-60.
doi: 10.1042/CS20080500.

Diabetic cardiomyopathy

Affiliations
Review

Diabetic cardiomyopathy

Omar Asghar et al. Clin Sci (Lond). 2009 May.

Abstract

Diabetic cardiomyopathy is a distinct primary disease process, independent of coronary artery disease, which leads to heart failure in diabetic patients. Epidemiological and clinical trial data have confirmed the greater incidence and prevalence of heart failure in diabetes. Novel echocardiographic and MR (magnetic resonance) techniques have enabled a more accurate means of phenotyping diabetic cardiomyopathy. Experimental models of diabetes have provided a range of novel molecular targets for this condition, but none have been substantiated in humans. Similarly, although ultrastructural pathology of the microvessels and cardiomyocytes is well described in animal models, studies in humans are small and limited to light microscopy. With regard to treatment, recent data with thiazolidinediones has generated much controversy in terms of the cardiac safety of both these and other drugs currently in use and under development. Clinical trials are urgently required to establish the efficacy of currently available agents for heart failure, as well as novel therapies in patients specifically with diabetic cardiomyopathy.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Summary of interactions between the myocardial and vascular changes present in diabetic hearts and their contribution to diabetic cardiomyopathy and heart failure
Ang II R1, AT1; IGF-1, insulin-like growth factor-1.
Figure 2
Figure 2. Electronmicrograph of a myocardial capillary from a diabetic patient, demonstrating luminal occlusion with basement membrane thickening

References

    1. Leyden E. Asthma and diabetes mellitus. Zeutschr. Klin. Med. 1881;3:358–364.
    1. Mayer J. Ueber den zusammenhang des diabetes mellitus miterkrankungen des herzens. Zeutschr. Klin. Med. 1888;14:212–239.
    1. Rubler S., Dlugash J., Yuceoglu Y. Z., Kumral T., Branwood A. W., Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am. J. Cardiol. 1972;30:595–602. - PubMed
    1. Hayat S. A., Patel B., Khattar R. S., Malik R. A. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin. Sci. 2004;107:539–557. - PubMed
    1. Thrainsdottir I. S., Aspelund T., Thorgeirsson G., Gudnason V., Hardarson T., Malmberg K., Sigurdsson G., Rydén L. The association between glucose abnormalities and heart failure in the population-based Reykjavik study. Diabetes Care. 2005;28:612–616. - PubMed

MeSH terms